1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. South America Plasma Fractionation Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. South America Plasma Fractionation Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising need for plasma-based treatments
- 5.1.2 Growing awareness of blood disorders
5.2 Market Opportunities
- 5.2.1 Expansion in the global healthcare market
- 5.2.2 Growth in blood plasma-based therapies
5.3 Future Trends
- 5.3.1 Advances in protein fractionation
- 5.3.2 Increase in the number of plasma-derived therapies
5.4 Impact of Drivers and Restraints
6. South America Plasma Fractionation Market Regional Analysis
6.1 South America Plasma Fractionation Market Overview
6.2 South America Plasma Fractionation Market Revenue 2019-2028 (US$ Million)
6.3 South America Plasma Fractionation Market Forecast Analysis
7. South America Plasma Fractionation Market Analysis – by Product
7.1 Immunoglobulin
- 7.1.1 Overview
- 7.1.2 Immunoglobulin: South America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Albumin
- 7.2.1 Overview
- 7.2.2 Albumin: South America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Coagulation Factor Concentrates
- 7.3.1 Overview
- 7.3.2 Coagulation Factor Concentrates: South America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Protease Inhibitors
- 7.4.1 Overview
- 7.4.2 Protease Inhibitors: South America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Other Plasma Products
- 7.5.1 Overview
- 7.5.2 Other Plasma Products: South America Plasma Fractionation Market – Revenue and Forecast to 2031 (US$ Million)
8. South America Plasma Fractionation Market Analysis – by Application
8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Neurology: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Immunology
- 8.2.1 Overview
- 8.2.2 Immunology: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Hematology
- 8.3.1 Overview
- 8.3.2 Hematology: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Critical Care
- 8.4.1 Overview
- 8.4.2 Critical Care: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Pulmonology
- 8.5.1 Overview
- 8.5.2 Pulmonology: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Other Applications
- 8.6.1 Overview
- 8.6.2 Other Applications: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9. South America Plasma Fractionation Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Other Applications: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Clinical Research Laboratories
- 9.2.1 Overview
- 9.2.2 Other Applications: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic Institutes
- 9.3.1 Overview
- 9.3.2 Other Applications: South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
10. South America Plasma Fractionation Market – South and Central America Analysis
10.1 South and Central America
- 10.1.1 South America Plasma Fractionation Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 South America Plasma Fractionation Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 Brazil:
South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Brazil: South America Plasma Fractionation Market Breakdown, by Product
- 10.1.1.1.2 Brazil: South America Plasma Fractionation Market Breakdown, by Application
- 10.1.1.1.3 Brazil: South America Plasma Fractionation Market Breakdown, by End User
- 10.1.1.2 Argentina:
South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Argentina: South America Plasma Fractionation Market Breakdown, by Product
- 10.1.1.2.2 Argentina: South America Plasma Fractionation Market Breakdown, by Application
- 10.1.1.2.3 Argentina: South America Plasma Fractionation Market Breakdown, by End User
- 10.1.1.3 Rest of South and Central America :
South America Plasma Fractionation Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Rest of South and Central America : South America Plasma Fractionation Market Breakdown, by Product
- 10.1.1.3.2 Rest of South and Central America : South America Plasma Fractionation Market Breakdown, by Application
- 10.1.1.3.3 Rest of South and Central America : South America Plasma Fractionation Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. South America Plasma Fractionation Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bharat Serums and Vaccines Limited (BSV)
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bio Products Laboratory Ltd.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Biotest AG.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CSL Limited
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Grifols, S.A.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Kedrion S.p.A
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Octapharma AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 SK Plasma
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights